EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.5.1.4 | CAY10400 | - |
Rattus norvegicus | |
3.5.1.4 | OMDM2 | 0.01 mM, 16% inhibition | Rattus norvegicus | |
3.5.1.4 | UCM707 | - |
Rattus norvegicus | |
3.5.1.4 | URB597 | - |
Rattus norvegicus | |
3.5.1.4 | VDM11 | - |
Rattus norvegicus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.1.4 | anandamide + H2O | Rattus norvegicus | - |
arachidonic acid + ethanolamine | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.1.4 | Rattus norvegicus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.5.1.4 | RBL-2H3 cell | basophilic leukemia cell. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase | Rattus norvegicus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.1.4 | anandamide + H2O | - |
Rattus norvegicus | arachidonic acid + ethanolamine | - |
? |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.5.1.4 | 0.0000005 | - |
- |
Rattus norvegicus | CAY10400 | |
3.5.1.4 | 0.000002 | - |
- |
Rattus norvegicus | URB597 | |
3.5.1.4 | 0.005 | - |
- |
Rattus norvegicus | VDM11 | |
3.5.1.4 | 0.05 | - |
- |
Rattus norvegicus | UCM707 |